INVESTMENTS IN INDIA
India's COVID-19 recovery rate improving, fatality rate declining: Health Ministry
The number of active COVID-19 cases stood at 93,322 while 91,818 people have recovered so far, of whom 4,835 cured in the last 24 hours.
China wields spiked sticks in Ladakh as India fights Covid-19
ET has reliably gathered that New Delhi has taken up the matter with Beijing th...
After rush to exit India in March & Apr, FPIs invest Rs 9k cr in May so far
The inflow comes following a net withdrawal of Rs 6,883 crore in ...
Why India needs to put cash in the hands of the poor
GoI has sedulously avoided direct disbursements to wage labourers who have no jobs and no recourse.
India now sixth worst-hit nation by COVID-19, surpasses Italy with an infection tally of 2,36,657
India went past Italy to become the sixth worst-hit nation by the COVID pandemic with the country registering a record single-day spike of 9,887 cases.
Should I invest in large cap funds or aggressive hybrid funds?
India coronavirus count jumps by over 5,600 in past 24 hours
Maharashtra reported more than 2,000 cases for the fourth day on run. Mumbai continued to be the biggest contributor with 60% of these cases. The state's total cases have now neared 40,000, accounting for almost 40% of the country’s cumulative tally. Tamil Nadu crossed the 13,000-mark, taking the state tally to 13,191 — second highest in India after Maharashtra.
Lack of medical investment, healthcare infra big challenges for India's COVID-19 fight: Fitch
"The continued lack of medical funding and healthcare infrastructure inform our view for the potential epidemic to be worse in India if it is not adequately contained," Fitch Solutions Country Risk and Industry Research (a unit of Fitch Group) said in its outlook for India's pharmaceutical market.
The road ahead turns darker for India, Asia's virus hotspot
A Bloomberg survey of economists estimates a 1.9% contraction in GDP in the current fiscal year.
Lockdown, Day 65: India faces a jobs paradox
A United Nations University study estimates that 104 mn Indians could fall below the World Bank-determined poverty line of $3.2 a day for lower-middle-income countries but the picture of where the Indian economy is headed should be a bit clearer tomorrow when the GDP data comes out.
COVID-19 helping accelerate investments in cloud, AI and cybersecurity: Anant Maheshwari
"No one company is going to solve a challenge like this alone, and it is going to take the private and public sectors working together to turn the tide on COVID-19. As we continue to work through the current situation and plan for the future, it's clear that the change required is significant - as is the potential opportunity across industries," Microsoft India President Anant Maheshwari said.
COVID-19 cases in India surge past 85,000, surpasses China tally
The nationwide tally of confirmed COVID-19 cases crossed 85,000 on Friday with more people testing positive for the deadly virus infection f...
Abu Dhabi Investment Authority in talks to invest in Jio platforms
ADIA follows Mubadala, the sister firm of the UAE’s largest sovereign wealth fund, which has already been in negotiations with Reliance Industries that owns Jio Platforms. It is not clear how much each of the funds will invest. Both entities, along with Saudi Arabia’s sovereign wealth fund Public Investment Fund, may invest close to $2 billion in RIL’s digital business unit.
Lockdown, Day 71: Mixed messages ahead
India is facing an unprecedented economic crisis, where some of the safe and traditional jobs are under the threat of being axed even as India breached the 2 lakh mark, with the highest spike of nearly 9000 cases in a day. Tough times ahead.
Strides Pharma to conduct trials in India for potential COVID-19 drug
The Bengaluru-based company has received approval from the Drug Controller General of India to conduct trials of favipiravir in the country, Strides Founder and Non-Executive Chairman Arun Kumar said on a post-earnings conference call, without giving any more details.
Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service